Investor Relations
Divio (DIVIO B) is listed on the Nasdaq First North Growth Market. Our headquarters are in Stockholm, with offices in Zurich and New York. We believe in remote working and our team is distributed globally.
Share Price Development
DIVIO B
0.0592
18:00:00-0.0338
-36.34%
Latest News
Divio invites investors to a presentation regarding the announced capital raise
Divio bjuder in investerare till presentation med anledning av offentliggjord kapitalanskaffning
The Board of Directors of Divio Technologies AB resolves on a directed share issue and a rights issue of units consisting of shares to accelerate the Agency strategy and strengthen the balance sheet.
Styrelsen i Divio Technologies AB beslutar om en riktad nyemission och en företrädesemission av units bestående av aktier för att accelerera Agency-strategin och stärka balansräkningen
Divio provides a trading update for Q1 2026 – preliminary numbers
Divio lämnar trading update för Q1 2026 – preliminära siffror
Divio reports from Extraordinary General Meeting
Divio rapporterar från extra bolagsstämma
NOTICE OF EXTRAORDINARY GENERAL MEETING IN DIVIO TECHNOLOGIES AB (PUBL)
KALLELSE TILL EXTRA BOLAGSSTÄMMA I DIVIO TECHNOLOGIES AB (PUBL)
Divio Technologies AB reports annual net sales growth of 35% and positive EBITDA for the full year
Divio Continues Strong Traction in Agency Strategy
Divio fortsätter sin starka utveckling inom agenturstrategin
Divio Launches Pure European Managed Hosting Solution
Divio lanserar helt europeisk lösning för managed hosting
Divio provides an update on its Agency strategy
Divio presenterar en uppdatering av sin Agency strategi
Divio secures an additional contract expansion worth SEK 500,000 with Swiss Healthcare Company
Divio säkrar ytterligare 500 000 SEK i utökat samarbete med schweiziskt läkemedelsföretag
"Divio Technologies AB (publ) reports 52% increase in net sales and positive EBITDA"
Livepresentation med Divios VD och CFO den 12 november kl. 13:00
Live presentation with Divio's CEO & CFO on November 12 at 13:00
Divio reports SEK 700,000 in enhanced collaboration with Swiss Healthcare Company
Divio rapporterar 700 000 SEK i utökat samarbete med schweiziskt läkemedelsföretag
Divio Announces CFO Leadership Transition
Subscribe to Our Newsletter
Important Dates
- Report
Interim Report Q3 (1 Jul - 30 Sep)
- Report
Interim Report Q2 (1 Apr - 30 Jun)
- Meeting
Annual General Meeting in Stockholm
- Report
Interim Report Q1 (1 Jan - 31 Mar)
- Report
Full Year and Q4 Report (1 Oct - 31 Dec)
- Report
Interim Report Q3 (1 Jul - 30 Sep)
- Report
Interim Report Q2 (1 Apr - 30 Jun)
- Meeting
Annual General Meeting in Stockholm
- Report
Interim Report Q1 (1 Jan - 31 Mar)
- Report
Full Year and Q4 Report (1 Oct - 31 Dec)
- Report
Interim Report Q3 (1 July - 30 September)
- Report
Interim Report Q2 (1 Apr - 30 Jun)
- Meeting
Annual General Meeting in Stockholm
- Report
Interim Report Q1 (1 Jan - 31 Mar)
- Report
Full Year and Q4 Report (1 Oct - 31 Dec)
- Report
Interim Report Q3 (1 Jul - 30 Sep)
- Report
Interim report Q2 (1 Apr - 30 Jun)
- Meeting
Annual General Meeting in Stockholm
- Report
Interim report Q1 (1 Jan - 30 March)
- Report
Annual Report 2022
- Report
Full year and Q4 report (1 October - 31 December)
- Report
Interim report Q3 (1 July - 30 September)
- Report
Half-year report (January - June 2022)
- Report
Annual Report 2021
- Report
Year-end report 2021